Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs

Structure

Volumn 7, Issue 2, 1999, Pages 131-142

  Stanfield, R L ^a   Cabezas, E ^a,c   Satterthwait, A C ^a,c   Stura, E A ^a,d   Profy, A T ^b,e   Wilson, I A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b REPLIGEN CORPORATION   (United States)

^c BURNHAM INSTITUTE   (United States)

^d CEA SACLAY   (France)

^e Procept Inc   (United States)

Author keywords

Antibody peptide complex; Fab fragment; HIV 1; Vaccine; X ray crystallography

Indexed keywords

GLYCOPROTEIN GP 120; IMMUNOGLOBULIN F(AB) FRAGMENT;

ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

EID: 0033080945     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80020-3     Document Type: Article

References (86)

1. 1. McCune, J.M., et al., & Weissman, I.L. (1988). Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53, 55-67.
2. 2. Moore, J.P., Trkola, A. & Dragic, T. (1997). Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551-562.
3. 3. Broder, C.C. & Collman, R.G. (1997). Chemokine receptors and HIV. J. Leukoc. Biol. 62, 20-29.
4. 4. LaRosa, G.J., et al., & Putney, S.D. (1990). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249, 932-935.
5. 5. LaRosa, G.J., et al., &. Putney, S.D. (1991). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science 253, 1146.
6. 6. LaRosa, G.J., et al., & Putney, S.D. (1991). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications. Science 251, 811.
7. 7. Javaherian, K., et al., & Matthews, T.J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA 86, 6768-6772.
8. 8. McKeating, J.A., Cordell, J., Dean, C.J. & Balfe, P. (1992). Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology 191, 732-742.
9. 9. Sattentau, Q.J. & Moore, J.P. (1991 ). Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174, 407-415.
10. 10. Hwang, S.S., Boyle, T.J., Lyerly, H.K. & Cullen, B.R. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
11. 11. Chesebro, B., Wehrly, K., Nishio, J. & Perryman, S. (1996). Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J. Virol. 70, 9055-9059.
12. 12. di Marzo Veronese, F., et al., & Lusso, P. (1993). Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. J. Biol. Chem. 268, 25894-25901.
13. 13. Wrin, T., Loh, T.P., Vennari, J.C., Schuitemaker, H. & Nunberg, J.H. (1995). Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69, 39-48.
14. 14. Ivanoff, L.A., et al., & Matthews, T.J. (1991). Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res. Hum. Retroviruses 7, 595-603.
15. 15. Hwang, S.S., Boyle, T.J., Lyerly, H.K. & Cullen, B.R. (1992). Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257, 535-537.
16. 16. Bhattacharyya, D., Brooks, B.R. & Callahan, L. (1996). Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses 12, 83-90.
17. 17. Speck, R.F., et al., & Goldsmith, M.A. (1997). Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71, 7136-7139.
18. 18. De Jong, J.J., De Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. (1992). Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66, 6777-6780.
19. 19. Fouchier, R.A., et al., & Schuitemaker, H. (1992). Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66, 3183-3187.
20. 20. Wyatt, R., et al., & Sodroski, J.G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
21. 21. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J. & Hendrickson, W.A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
22. 22. Rizzuto, C.D., et al., & Sodroski, J. (1998). A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953.
23. 23. Wilmot, C.M. & Thornton, J.M. (1988). Analysis and prediction of the different types of β-turn in proteins. J. Mol. Biol. 203, 221-232.
24. 24. White-Scharf, M.E., Potts, B.J., Smith, L.M., Sokolowski, K.A., Rusche, J.R. & Silver, S. (1993). Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. Virology 192, 197-206.
25. 25. Valenzuela, A., Blanco, J., Krust, B., Franco, R. & Hovanessian, A.G. (1997). Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells. J. Virol. 71, 8289-8298.
26. 26. Rini, J.M., Stanfield, R.L., Stura, E.A., Salinas, P.A., Profy, A.T. & Wilson, I.A. (1993). Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl Acad. Sci. USA 90, 6325-6329.
27. 27. Stanfield, R.L., Takimoto-Kamimura, M., Rini, J.M., Profy, A.T. & Wilson, I.A. (1993). Major antigen-induced domain rearrangements in an antibody. Structure 1, 83-93.
28. 28. Ghiara, J.B., Stura, E.A., Stanfield, R.L., Profy, A.T. & Wilson, I.A. (1994). Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
29. 29. Ghiara, J.B., Ferguson, D.C., Satterthwait, A.C., Dyson, H.J. & Wilson, I.A. (1997). Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site. J. Mol. Biol. 266, 31-39.
30. 30. Burgess, A.W. & Leach, S.J. (1973). An obligatory α-helical amino acid residue. Biopolymers 12, 2599-2605.
31. 31. Marshall, G.R. & Bosshard, H.E. (1972). Angiotensin II. Studies on the biologically active conformation. Circ. Res. 31, Supplement 2, 143-150.
32. 32. Brünger, A.T., Krukowski, A. & Erickson, J.W. (1990). Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Crystallogr. A 46, 585-593.
33. 33. Engh, R.A. & Huber, R. (1991 ). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. A 47, 392-400.
34. 34. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S. & Foeller, C. (1991 ). Sequences of Proteins of Immunological Interest. US Department of Health and Human Services.
35. 35. Ratner, L., et al., & Wong-Staal, F. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
36. 36. Laskowski, R.A., MacArthur, M.W., Hutchinson, E.G. & Thornton, J.M. (1992). Stereochemical quality of protein structure coordinates. Proteins 12, 345-364.
37. 37. Stanfield, R.L., Fieser, T.M, Lerner, R.A. & Wilson, I.A. (1990). Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248, 712-719.
38. 38. Arevalo, J.H., Stura, E.A., Taussig, M.J. & Wilson, I.A. (1993). Three-dimensional structure of an anti-steroid Fab' and progesterone - Fab' complex. J. Mol. Biol. 231, 103-118.
39. 39. Al-Lazikani, B., Lesk, A.M. & Chothia, C. (1997). Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273, 927-948.
40. 40. Martin, A.C. & Thornton, J.M. (1996). Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J. Mol. Biol. 263, 800-815.
41. 41. Brünger, A.T., Leahy, D.J., Hynes, T.R. & Fox, R.O. (1991). 2.9 Å Resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten. J. Mol. Biol. 221, 239-256.
42. 10-staphylococcal nuclease complex at 2.9 Å resolution. J. Mol. Biol. 253, 559-575.
43. 43. Marquart, M., Deisenhofer, J., Huber, R. & Palm, W. (1980). Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 Å and 1.9 Å resolution. J. Mol. Biol. 141, 369-391.
44. 44. He, X.M., Ruker, F., Casale, E. & Carter, D.C. (1992). Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 89, 7154-7158.
45. 45. Altschuh, D., Vix, O., Rees, B. & Thierry, J.C. (1992). A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex. Science 256, 92-94.
46. 46. Shirai, H., Kidera, A. & Nakamura, H. (1996). Structural classification of CDR-H3 in antibodies. FEBS Lett. 399, 1-8.
47. 47. Connolly, M.L. (1983). Solvent-accessible surfaces of proteins and nucleic acids. Science 221, 709-713.
48. 48. Wilson, I.A., et al., & Stura, E.A. (1991). Structural aspects of antibodies and antibody-antigen complexes. Ciba Foundation Symposium. 159, 13-28; discussion 28-39.
49. 49. Stanfield, R.L. & Wilson, I.A. (1993). X-ray crystallographic studies of antibody-peptide complexes. Immunomethods 3, 211 -221.
50. 50. Jellis, C.L., et al., & Gray, G.S. (1993). Defining critical residues in the epitope for a HIV-neutralizing monoclonal antibody using phage display and peptide array technologies. Gene 137, 63-68.
51. 51. Catasti, P., Fontenot, J.D., Bradbury, E.M. & Gupta, G. (1995). Local and global structural properties of the HIV-MN V3 loop. J. Biol. Chem. 270, 2224-2232.
52. 52. Gupta, G., Anantharamaiah, G.M., Scott, D.R., Eldridge, J.H. & Myers, G. (1993). Solution structure of the V3 loop of a Thailand HIV isolate. J. Biomol. Struct. Dyn. 11, 345-366.
53. 53. Chandrasekhar, K., Profy, A.T. & Dyson, H.J. (1991). Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry 30, 9187-9194.
54. 54. Vu, H.M., de Lorimier, R., Moody, M.A., Haynes, B.F. & Spicer, L.D. (1996). Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CANOA based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF. Biochemistry 35, 5158-5165.
55. 55. Vranken, W.F., et al., & Borremans, F.A. (1996). Conformational features of a synthetic cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions. Eur. J. Biochem. 236, 100-108.
56. 56. Sarma, A.V., Raju, T.V. & Kunwar, A.C. (1997). NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120. J. Biochem. Biophys. Methods 34, 83-98.
57. 57. Tolman, R.L., et al., & Conley, A.J. (1993). Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties. Int. J. Pept. Protein Res. 41, 455-466.
58. 58. Jelinek, R., Terry, T.D., Gesell, J.J., Malik, P., Perham, R.N. & Opella, S.J. (1997). NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein. J. Mol. Biol. 266, 649-655.
59. 59. Huang, X., Smith, M.C., Berzofsky, J.A. & Barchi, J.J., Jr. (1996). Structural comparison of a 15 residue peptide from the V3 loop of HIV-1IIIb and an O-glycosylated analogue. FEBS Lett. 393, 280-286.
60. 60. Huang, X., et al., & Garrity, R.R. (1997). Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135. Biochemistry 36, 10846-10856.
61. 61. Markert, R.L., et al., & Griesinger, C. (1996). Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2. Eur. J. Biochem. 237, 188-204.
62. 62. Zvi, A., Kustanovich, I., Hayek, Y., Matsushita, S. & Anglister, J. (1995). The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions. FEBS Lett. 368, 267-270.
63. 63. Zvi, A., Feigelson, D.J., Hayek, Y. & Anglister, J. (1997). Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy. Biochemistry 36, 8619-8627.
64. 64. Bernstein, F.C., et al., & Tasumi, M. (1977). The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542.
65. 65. Housset, D., Habersetzer-Rochat, C., Astier, J.P. & Fontecilla-Camps, J.C. (1994). Crystal structure of toxin II from the scorpion Androctonus australis Hector refined at 1.3 Å resolution. J. Mol. Biol. 238, 88-103.
66. 66. Mande, S.C., Mehra, V., Bloom, B.R. & Hol, W.G. (1996). Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science 271, 203-207.
67. d MHC class I complexed with the HIV-1-derived peptide P18-110 at 2.4 Å resolution: implications for T cell and NK cell recognition. Immunity 9, 199-208.
68. 68. Brünger, A.T. (1990). Extension of molecular replacement: a new search strategy based on Patterson correlation refinement. Acta Crystallogr. A 46, 46-57.
69. 69. Harada, Y., Lifchitz, A., Berthou, J. & Jolles, P. (1981 ). A translation function combining packing and diffraction information: an application to lysozyme (high-temperature form). Acta Crystallogr. A 37, 398-406.
70. 70. Jones, T.A. (1985). Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. Methods Enzymol. 115, 157-171.
71. 71. Israel, M., Chirino, A.J. & Schuller, D.J. (1996). TOM/FRODO, Alberta/Caltech Version 3.3.
72. 72. Brünger, A.T. (1992). X-PLOR Version 3.1. Yale University Press, New Haven, CT, USA.
73. 73. Fitzgerald, P.M.D. (1988). MERLOT, an integrated package of computer programs for the determination of crystal structures by molecular replacement. J. Appl. Crystallogr. 21, 273-278.
74. 74. Kraulis, P. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of proteins. J. Appl. Crystallogr. 24, 946-950.
75. 75. Esnouf, R.M. (1997). An extensively modified version of MOLSCRIPT that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15, 112-113, 132-134.
76. 76. Merritt, E.A. & Murphy, M.E.P. (1994). Raster3D Version 2.0 - a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869-873.
77. 77. Bacon, D.J. & Anderson, W.F. (1988). A fast algorithm for rendering space-filling molecule pictures. J. Mol. Graph. 6, 219-220.
78. 78. Nicholls, A., Sharp, K.A. & Honig, B. (1991 ). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281 -296.
79. 79. Ferrin, T.E., Huang, C.C., Jarvis, L.E. & Langridge, R. (1988). The MIDAS display system. J. Mol. Graph. 6, 13-27.
80. 80. Huang, C.C., Pettersen, E.F., Klein, T.E., Ferrin, T.E. & Langridge, R. (1991 ). Conic: a fast renderer for space-filling molecules with shadows. J. Mol. Graph. 9, 230-236.
81. 81. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
82. 82. Xuong, N.-H., Nielsen, C., Hamlin, R. & Anderson, D. (1985). Strategy for data collection from protein crystals using a multiwire counter area detector diffractometer. J. Appl. Crystallogr. 18, 342-351.
83. 83. Howard, A.J., Nielsen, C. & Xuong, N.H. (1985). Software for a diffractometer with multiwire area detector. Methods Enzymol. 114, 452-472.
84. 84. Sheriff, S., Hendrickson, W.A. & Smith, J.L. (1987). Structure of myohemerythrin in the azidomet state at 1.7/1.3 Å resolution. J. Mol. Biol. 197, 273-296.
85. 85. Gelin, B.R. & Karplus, M. (1979). Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment. Biochemistry 18, 1256-1268.
86. 86. McDonald, I., & Thornton, J. (1995) The application of hydrogen bonding analysis in X-ray crystallography to help orientate asparagine, glutamine and histidine side chains. Protein Eng. 8, 217-224.